T2D Logo (EUIPO, 01/12/2016)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark T2D was filed as Figurative mark on 01/12/2016 at the European Union Intellectual Property Office. The current status of the mark is "Application refused".
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #One numeral
| Trademark form | Figurative mark |
| File reference | 014994041 |
| Application date | January 12, 2016 |
Trademark owner
One Marina Park Drive Suite 1300
02210 Boston,
US
02210 Boston,
US
goods and services
5
Pharmaceutical preparations for the treatment of obesity and metabolic diseases/disorders
10
Drug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of obesity and metabolic diseases/disorders
41
Development and dissemination of educational materials of others in the fields of obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith
42
Research and development of pharmaceutical preparations, products and technology in the fields of obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; medical and scientific research in the fields of obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals
44
Medical information services, namely, providing information on the topics of obesity, and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, pharmaceuticals, clinical trials, drug delivery technologies, and administration of pharmaceuticals
ID: 11014994041